Neurocrine Biosciences Stock: 'House Full Of Options' (NASDAQ:NBIX)

seekingalpha.com · 2026-08-22

Neurocrine Biosciences (NBIX) buy thesis: Ingrezza-led cash flows, new launches, and pipeline optionality. Read here for a detailed analysis.